Delix Therapeutics Closes $70 Million Series A Financing To Advance Pipeline Of Novel Psychoplastogen Therapeutics To Treat Brain Disorders
Amount Raised
$70 Million
Round Type
Series A
BostonBiotechnologyData And AnalyticsHealth CareScience And EngineeringDescription
Preclinical neuroscience company Delix Therapeutics (the "Company"), today announced the closing of a $70 million Series A financing round. The round was led by ARTIS Ventures, RA Capital Management, and founding investor OMX Ventures, with participation from a diverse syndicate of life sciences and psychedelic investment funds. The Company expects to use the proceeds to advance two lead candidates through Phase 1 clinical trials, further expand its drug discovery platform of novel neuroplasticity-promoting compounds known as psychoplastogens, and continue to rapidly grow its world-class team.
Quick answer
Delix Therapeutics raised $70 Million in a Series A round, dated September 27, 2021. Delix Therapeutics is based in Boston, Massachusetts, United States.
- How much did Delix Therapeutics raise?
- Delix Therapeutics raised $70 Million in a Series A round on September 27, 2021.
- What does Delix Therapeutics do?
- Delix Therapeutics is applying modern tools of pharmaceutical development to some of nature's most ancient therapies, psychedelics.
- Where is Delix Therapeutics based and how big is it?
- Delix Therapeutics is based in Boston, Massachusetts, United States.
- Who are the decision-makers at Delix Therapeutics?
- Fundz holds 1 contact at Delix Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Data And Analytics and Science And Engineering around the same time
Companies in the same sectors as Delix Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Cardurion Pharmaceuticals raised an undisclosed amount on October 27, 2021.
- American Bitcoin raised $18M on October 20, 2021.
- Envisagenics raised $19M on October 19, 2021.
- Exscientia raised $510M (Post-IPO Equity) on October 5, 2021.
- Envisagenics raised an undisclosed amount (Series A) on September 29, 2021.
- HealthSnap raised $5M on November 10, 2021.
Who to call at Delix Therapeutics, and when
A new round usually means Delix Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Delix Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Delix Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Delix Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Delix Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansDelix Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.